Hepatitis B Virus Reactivation during Successful Treatment of Hepatitis C Virus with Sofosbuvir and Simeprevir

Clinical Infectious Diseases

Volumn 61, Issue 8, 2015, Pages 1304-1306

  Collins, Jeffrey M ^a   Raphael, Kara Loren ^b   Terry, Charles ^b   Cartwright, Emily J ^a,e   Pillai, Anjana ^c,d   Anania, Frank A ^c,e   Farley, Monica M ^a,e  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Medicine ^*  (United States)

^c Division of Digestive Diseases   (United States)

^d EMORY UNIVERSITY   (United States)

^e ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Acute hepatitis; HBV reactivation; HBV HCV coinfection; Simeprevir; Sofosbuvir

Indexed keywords

ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; EMTRICITABINE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; PEGINTERFERON ALPHA; RIBAVIRIN; SIMEPREVIR; SOFOSBUVIR; TENOFOVIR; ANTIVIRUS AGENT;

ABDOMINAL PAIN; ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMEGALY; HUMAN; INTERNATIONAL NORMALIZED RATIO; JAUNDICE; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PORTAL HYPERTENSION; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS REACTIVATION; COMBINATION DRUG THERAPY; COMPLICATION; HEPATITIS C, CHRONIC; MIXED INFECTION; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; RISK FACTOR; VIROLOGY;

ADMINISTRATION, ORAL; ANTIVIRAL AGENTS; COINFECTION; DRUG THERAPY, COMBINATION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SIMEPREVIR; SOFOSBUVIR;

EID: 84943328235     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ474     Document Type: Article

References (12)

1. Lawitz E, Sulkowski MS, Ghalib R, et al. Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study. Lancet 2014; 384:1756-65.
2. Kruse RL, Kramer JR, Tyson GL, et al. Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients. Hepatology 2014; 60:1871-8.
3. Lawitz E, Mangia A, Wyles D, et al. Sofosbuvir for previously untreated chronic hepatitis C infection. N Engl J Med 2013; 368:1878-87.
4. Chu CM, Yeh CT, Liaw YF. Low-level viremia and intracellular expression of hepatitis B surface antigen (HBsAg) in HBsAg carriers with concurrent hepatitis C virus infection. J Clin Microbiol 1998; 36:2084-6.
5. Liu JY, Sheng YJ, Hu HD, et al. The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysis. Virol J 2012; 9:186.
6. Yalcin K, Degertekin H, Yildiz F, Kilinc N. A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with ?-interferon and ribavirin. J Gastroenterol 2003; 38:796-800.
7. Liaw YF, Chen YC, Sheen IS, Chien RN, Yeh CT, Chu CM. Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. Gastroenterology 2004; 126:1024-9.
8. Biliotti E, Kondili LA, Furlan C, et al. Acute hepatitis B in patients with or without underlying chronic HCV infection. J Infect 2008; 57:152-7.
9. Liu CJ, Chuang WL, Lee CM, et al. Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. Gastroenterology 2009; 136:496-504.
10. Brunetto MR, Cerenzia MT, Oliveri F, et al. Monitoring the natural course and response to therapy of chronic hepatitis B with an automated semi-quantitative assay for IgM anti-HBc. J Hepatol 1993; 19:431-6.
11. American Association for the Study of Liver Diseases/Infectious Diseases Society of America/International AIDS Society-USA. Recommendations for testing, managing, and treating hepatitis C. Available at: http://www.hcvguidelines.org. Accessed 5 March 2015.
12. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45: 507-39.